癌バイオマーカーの世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23NOV179)◆商品コード:IMARC23NOV179
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年10月
◆ページ数:147
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

市場概要世界の癌バイオマーカー市場規模は2022年に247億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に12.95%の成長率(CAGR)を示し、2028年までに537億米ドルに達すると予測しています。

癌バイオマーカーは、血液、組織、体液中にがん細胞が存在することを示す生体分子です。バイオマーカーは、がん細胞自体によって産生される場合もあれば、がんに反応して体内の他の組織によって産生される場合もあります。一般的ながんには、乳がん、前立腺がん、子宮頸がん、肺がん、大腸がんなどがあります。これらは、病気の診断、進行のモニタリング、浸潤性腫瘍と非浸潤性腫瘍の区別、再発の可能性の予測、治療効果の記録などに広く用いられています。バイオマーカーには、酵素、タンパク質、核酸、遺伝子、特定の細胞、ペプチドなどがあります。その結果、バイオマーカーは予後予測、代替エンドポイント、診断、個別化医薬品として広く使用されています。

癌バイオマーカー市場の動向
世界的な癌罹患率の増加により、市場には明るい展望が生まれています。バイオマーカーは、がんの早期発見や治療・管理中に、転帰を正確かつ確実に予測するために広く利用されています。これに伴い、汚染レベルの上昇、喫煙傾向、摂取習慣の悪化による肺がんの罹患率の増加が、市場の成長を増大させています。さらに、次世代シーケンシング(NGS)、ポリメラーゼ連鎖反応(PCR)、遺伝子発現プロファイリング(マイクロアレイ)、治療後のがん再発予測を支援する人工知能(AI)など、遺伝子バイオマーカー探索におけるさまざまな技術進歩が、市場成長に弾みをつけています。また、早期診断の重要性に対する医療従事者や患者の意識の高まりや、標準的な診断法の欠如によるがん治療の個別化医療への大きなシフトが、市場成長に好影響を与えています。その他、医療業界の著しい成長、広範な研究開発(R&D)活動、医薬品開発プロセス強化のための様々な政府イニシアチブの実施などが、市場の成長を促進すると予想されます。

主な市場セグメンテーション
IMARC Groupは、世界の癌バイオマーカー市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、プロファイリング技術、生体分子、癌タイプ、用途、エンドユーザーに基づいて市場を分類しています。

プロファイリング技術別内訳
オミック技術
イメージング技術
イムノアッセイ
細胞遺伝学

生体分子別内訳
遺伝子バイオマーカー
タンパク質バイオマーカー
糖鎖バイオマーカー

がんタイプ別内訳
乳がん
肺がん
大腸がん
前立腺がん
胃がん
その他

アプリケーション別内訳
診断薬
予後診断
リスク評価
創薬・医薬品開発
その他

エンドユーザー別内訳
病院
学術・研究機関
外来手術センター
診断研究所
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境
業界の競争環境は、Abbott Laboratories、Agilent Technologies Inc.、Becton Dickinson and Company、bioMérieux SA、Danaher Corporation、F. Hoffmann-La Roche AG、General Electric Company、Illumina Inc.、Qiagen N.V.、Sino Biological Inc.、Thermo Fisher Scientific Inc.などの主要企業のプロフィールとともに調査されています。

本レポートで扱う主な質問
1. 2022年の世界の癌バイオマーカー市場規模は?
2. 2023〜2028年の世界の癌バイオマーカー市場の予想成長率は?
3. 癌バイオマーカーの世界市場を牽引する主要因は?
4. COVID-19が世界の癌バイオマーカー市場に与えた影響は?
5. 癌バイオマーカーの世界市場における生体分子別内訳は?
6. 癌バイオマーカーの世界市場におけるがんタイプ別内訳は?
7. 癌バイオマーカーの世界市場における主要地域は?
8. 癌バイオマーカーの世界市場における主要プレイヤー/企業は?

1 序論
2 範囲・方法
3 エグゼクティブサマリー
4 イントロダクション
5 世界の癌バイオマーカー市場
6 世界の癌バイオマーカー市場:プロファイリング技術別分析
7 世界の癌バイオマーカー市場:生体分子別分析
8 世界の癌バイオマーカー市場:がんタイプ別分析
9 世界の癌バイオマーカー市場:用途別分析
10 世界の癌バイオマーカー市場:エンドユーザー別分析
11 世界の癌バイオマーカー市場:地域別分析
12 SWOT分析
13 バリューチェーン分析
14 ポーターズファイブフォース分析
15 価格分析
16 競争状況

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Profiling Technology
6.1 Omic Technologies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Technologies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunoassays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytogenetics
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Biomolecule
7.1 Genetic Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Protein Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Glyco-Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Cancer Type
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Stomach Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Prognostics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Risk Assessment
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Drug Discovery and Development
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutions
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Ambulatory Surgical Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Diagnostic Laboratories
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Agilent Technologies Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 bioMérieux SA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 General Electric Company
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Illumina Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Qiagen N.V.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sino Biological Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis

Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2022
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2022
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2022
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2022
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2022
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2022
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2022
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 癌バイオマーカーの世界市場2023~2028:産業動向、シェア、規模、成長、機会・予測(Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆